Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
| Autor: | Braggin JE; Department of Neurology University of Washington Seattle Washington., Bucks SA; Department of Neurology University of Washington Seattle Washington., Course MM; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington., Smith CL; Department of Neurology University of Washington Seattle Washington., Sopher B; Department of Neurology University of Washington Seattle Washington., Osnis L; Department of Neurology University of Washington Seattle Washington., Shuey KD; Department of Neurology University of Washington Seattle Washington., Domoto-Reilly K; Department of Neurology University of Washington Seattle Washington., Caso C; Department of Neurology University of Washington Seattle Washington., Kinoshita C; Department of Neurological Surgery University of Washington Seattle Washington., Scherpelz KP; Department of Pathology University of Washington Seattle Washington., Cross C; School of Medicine University of Utah Salt Lake City Utah., Grabowski T; Department of Neurology University of Washington Seattle Washington.; Department of Radiology University of Washington Seattle Washington., Nik SHM; Genetics and Evolution University of Adelaide Adelaide South Australia., Newman M; Genetics and Evolution University of Adelaide Adelaide South Australia., Garden GA; Department of Neurology University of Washington Seattle Washington.; Department of Pathology University of Washington Seattle Washington., Leverenz JB; Cleveland Lou Ruvo Center for Brain Health Cleveland OH., Tsuang D; Department of Neurology University of Washington Seattle Washington.; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington.; Department of Psychiatry & Behavioral Sciences University of Washington Seattle Washington.; Geriatric Research, Education, and Clinical Center VA Puget Sound Health Care System Seattle Washington., Latimer C; Department of Pathology University of Washington Seattle Washington., Gonzalez-Cuyar LF; Department of Pathology University of Washington Seattle Washington., Keene CD; Department of Pathology University of Washington Seattle Washington., Morrison RS; Department of Neurological Surgery University of Washington Seattle Washington., Rhoads K; Department of Neurology University of Washington Seattle Washington., Wijsman EM; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington.; Univeristy of Washington Department of Biostatistics Seattle Washington., Dorschner MO; Department of Pathology University of Washington Seattle Washington.; Department of Psychiatry & Behavioral Sciences University of Washington Seattle Washington.; UW Medicine Center for Precision Diagnostics University of Washington Seattle Washington., Lardelli M; Genetics and Evolution University of Adelaide Adelaide South Australia., Young JE; Department of Pathology University of Washington Seattle Washington., Valdmanis PN; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington., Bird TD; Department of Neurology University of Washington Seattle Washington.; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington.; Geriatric Research, Education, and Clinical Center VA Puget Sound Health Care System Seattle Washington., Jayadev S; Department of Neurology University of Washington Seattle Washington.; Division of Medical Genetics Department of Medicine University of Washington Seattle Washington. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Mar 10; Vol. 6 (4), pp. 762-777. Date of Electronic Publication: 2019 Mar 10 (Print Publication: 2019). |
| DOI: | 10.1002/acn3.755 |
| Abstrakt: | Objective: Autosomal-dominant familial Alzheimer disease (AD) is caused by by variants in presenilin 1 ( PSEN1 ), presenilin 2 ( PSEN2 ), and amyloid precursor protein ( APP ). Previously, we reported a rare PSEN2 frameshift variant in an early-onset AD case (PSEN2 p.K115Efs*11). In this study, we characterize a second family with the same variant and analyze cellular transcripts from both patient fibroblasts and brain lysates. Methods: We combined genomic, neuropathological, clinical, and molecular techniques to characterize the PSEN2 K115Efs*11 variant in two families. Results: Neuropathological and clinical evaluation confirmed the AD diagnosis in two individuals carrying the PSEN2 K115Efs*11 variant. A truncated transcript from the variant allele is detectable in patient fibroblasts while levels of wild-type PSEN2 transcript and protein are reduced compared to controls. Functional studies to assess biological consequences of the variant demonstrated that PSEN2 K115Efs*11 fibroblasts secrete less A β Interpretation: These data suggest that PSEN2 K115Efs*11 is a likely pathogenic variant associated with AD. We uncovered novel PSEN2 alternative transcripts in addition to previously reported PSEN2 splice isoforms associated with sporadic AD. In the context of a frameshift, these alternative transcripts return to the canonical reading frame with potential to generate deleterious protein products. Our findings suggest novel potential mechanisms by which PSEN variants may influence AD pathogenesis, highlighting the complexity underlying genetic contribution to disease risk. Competing Interests: The authors have no conflicts of interest to disclose. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |